Report copyright - N° Intergroupe - Unicancer (UCBG) · Randomized, double-blind, multicentric phase III trial evaluating the safety and benefit of adding everolimus to adjuvant hormone therapy in
Please pass captcha verification before submit form
Please pass captcha verification before submit form